You have 9 free searches left this month | for more free features.

large granular lymphocytes leukemia

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B Acute Lymphoblastic Leukemia Trial in Duarte (drug, procedure, other)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Autologous Anti-CD19 CAR-expressing T Lymphocytes
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Jan 30, 2023

Hematologic Malignancy Trial in Bologna

Recruiting
  • Hematologic Malignancy
    • Bologna, Italy
      Programma Dipartimentale Terapie Cellulari Avanzate
    Apr 17, 2023

    Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Refractory, Non-Hodgkin's Lymphoma, Relapsed

    Recruiting
    • Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • Autologous CAR19 T lymphocytes
    • Prague, Czechia
      Institute of Hematology and Blood Transfusion, Czech Republic
    Aug 3, 2022

    Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic

    Completed
    • Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
    • +76 more
    • fludarabine phosphate
    • +6 more
    • Tucson, Arizona
    • +10 more
    Jan 17, 2020

    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

    Completed
    • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
    • +99 more
    • alemtuzumab
    • +6 more
    • Denver, Colorado
    • +6 more
    Jan 15, 2020

    Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Denmark, Italy, United

    Completed
    • Chronic Lymphocytic Leukemia
    • +8 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +8 more
    • Rochester, Minnesota
    • +4 more
    Jun 20, 2019

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 12, 2023

    T-Cell Large Granular Lymphocytic Leukemia, Leukemia, T-Cell Large Granular Lymphocytic Trial run by the NCI (Hu-MiK-Beta-1)

    Completed
    • T-Cell Large Granular Lymphocytic Leukemia
    • Leukemia, T-Cell Large Granular Lymphocytic
    • Hu-MiK-Beta-1
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 10, 2019

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +11 more
    • Zilovertamab vedotin
    • Duarte, California
    • +13 more
    Jan 12, 2023

    Incidence and Predictors of Bleeding During and Following ERCP

    Recruiting
    • Bleeding UGI (During or Post-ERCP)
      • Calgary, Alberta, Canada
        Peter Lougheed Center
      Jun 26, 2023

      Improved Methods of Cell Selection for Bone Marrow Transplant

      Recruiting
      • Graft-Versus-Host Disease
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)

      Recruiting
      • Hairy Cell Leukemia
      • Hairy Cell Leukemia Variant
      • CD22CART cell infusion
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Acute Myeloid Leukemia Trial in Nanjing (Chidamide, Cladribine)

      Recruiting
      • Acute Myeloid Leukemia
      • Nanjing, Jiangsu, China
        Department of Hematology, Zhongda Hospital Southeast University,
      Apr 23, 2022

      Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

      Active, not recruiting
      • Acute Lymphocytic Leukemia
      • Lymphoma
      • Biological/Genetically Modified T cells
      • Cyclophosphamide-based chemotherapy
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 3, 2023

      Patients Undergoing CAR-T Cell Therapy (CAR_21_01)

      Recruiting
      • CAR-T Therapy Complications
        • Bologna, Italy
          IRCC, University Hospital of Bologna
        Mar 18, 2022

        Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

        Recruiting
        • Relapsed or Refractory CD19+ B-cell Lymphoma
        • +2 more
        • TBI-2001
        • +2 more
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Jul 26, 2023

        Chronic Lymphocytic Leukemia Trial in Portland (drug, procedure, biological, other)

        Not yet recruiting
        • Chronic Lymphocytic Leukemia
        • Portland, Oregon
          OHSU Knight Cancer Institute
        Jul 12, 2023

        Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

        Completed
        • Adult Acute Megakaryoblastic Leukemia (M7)
        • +13 more
        • Philadelphia, Pennsylvania
          Thomas Jefferson University
        Feb 2, 2023

        Evaluation of Patients With HAM/TSP

        Recruiting
        • HTLV-I Infection
        • Tropical Spastic Paraparesis
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 25, 2023

          Minimal Residual Disease, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Adult Acute Myeloid

          Completed
          • Minimal Residual Disease
          • +3 more
          • Daratumumab
          • +2 more
          • Columbus, Ohio
            Ohio State University Comprehensive Cancer Center
          Mar 2, 2022

          Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia Trial in Bergamo (Blinatumomab Expanded T-cells (BET))

          Active, not recruiting
          • Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia
          • Blinatumomab Expanded T-cells (BET)
          • Bergamo, Italy
            ASST - Papa Giovanni XXIII
          Dec 22, 2021

          Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

          Completed
          • Adult Nasal Type Extranodal NK/T-cell Lymphoma
          • +35 more
          • Duarte, California
          • +4 more
          Dec 24, 2019

          Hematological Malignancies - SANGUINE

          Recruiting
          • Hematologic Malignancy
          • Blood sampling for HemaChip screening/diagnostic testing
          • Bone marrow sampling
          • Olomouc, Czechia
          • +3 more
          Feb 9, 2023

          Chronic Lymphocytic Leukemia Trial in Madison ([U-13C]glucose, [13C5]glutamine)

          Recruiting
          • Chronic Lymphocytic Leukemia
          • [U-13C]glucose
          • [13C5]glutamine
          • Madison, Wisconsin
            University of Wisconsin
          Jun 15, 2022

          Acute Lymphoblastic Leukemia, Pediatric Trial in Canada, United States (Pegaspargase, Erwinia asparaginase, Cyclophosphamide)

          Active, not recruiting
          • Acute Lymphoblastic Leukemia, Pediatric
          • Boston, Massachusetts
          • +8 more
          Nov 10, 2022